Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

47437

Sigma-Aldrich

Fmoc-D-Tic-OH

≥98.0% (TLC)

Synonym(s):

(R)-N-Fmoc-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C25H21NO4
CAS Number:
Molecular Weight:
399.44
Beilstein/REAXYS Number:
7499344
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:

assay

≥98.0% (TLC)

optical activity

[α]20/D −25.0±2°, c = 0.6% in methanol

application(s)

peptide synthesis

functional group

Fmoc

storage temp.

2-8°C

SMILES string

OC(=O)[C@H]1Cc2ccccc2CN1C(=O)OCC3c4ccccc4-c5ccccc35

InChI

1S/C25H21NO4/c27-24(28)23-13-16-7-1-2-8-17(16)14-26(23)25(29)30-15-22-20-11-5-3-9-18(20)19-10-4-6-12-21(19)22/h1-12,22-23H,13-15H2,(H,27,28)/t23-/m1/s1

InChI key

LIRBCUNCXDZOOU-HSZRJFAPSA-N

Other Notes

FMOC-D-Tic is employed e.g. for the solid-phase synthesis of Bradykinin antagonists[1][2]

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

C Thurieau et al.
Journal of medicinal chemistry, 39(10), 2095-2101 (1996-05-10)
We report here on the synthesis and pharmacological properties of a new series of small linear and cyclic peptides derived from the five C-terminal amino acid residues of second-generation bradykinin receptor antagonists. Variations of the two first residues of the
V S Goodfellow et al.
Journal of medicinal chemistry, 39(7), 1472-1484 (1996-03-29)
We report a systematic probing of the structural requirements of the bradykinin (BK) type 2 (B(2)) receptor for antagonist activity by incorporating N-alkyl-amino acid residues at positions 7 and 8 of a potent antagonist sequence. Compound 1 (D-Arg(0)-Arg(1)-Pro(2)-Hyp(3)-Gly(4)-Thi(5)-Ser(6)-D-Tic(7)-N-Chg (8)-Arg(9), CP-0597)(1,2)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service